|
|
||||||||
Servicio de Endocrinología, Hospital Ramón y Cajal, Carretera de Colmenar, Km 9, 28034 Madrid, Spain
1 Servicio de Endocrinología, Hospital Carlos III-C.I.C., Instituto de Salud Carlos III, Sinesio Delgado, 10-12, 28029 Madrid, Spain.
(Requests for offprints should be addressed to L Cacicedo; Email: lcacicedo{at}hotmail.com)
In previous studies we demonstrated that vasoactive intestinal peptide (VIP) mediation, and interactions between mitogen-activated protein kinase (MAPK) and cAMP/protein kinase A (PKA) signaling pathways are implicated in insulin-like growth factor I (IGF-I)- and VIP-induced lactotroph proliferation. These facts led us to investigate the intracellular mechanisms involved in IGF-I- and VIP-induced lactotroph proliferation. Exposure of cultured male rat pituitary cells to IGF-I (107 M) or VIP (107 M) stimulated the MAPK cascade. Studies in GH4C1 cells, with an expression vector for Rap1 GTPase-activating protein (Rap1 GAP1), demonstrated reduced VIP-induced MAPK activation, indicating that VIP-dependent activation of the extracellular signal-regulated kinase (ERK) pathway requires PKA-Rap1 signaling. IGF-I induced cAMP-response element (CRE)-binding protein (CREB) phosphorylation through the Ras-MAPK pathway, whereas VIP phosphorylated CREB directly via PKA. The mechanisms that regulate IGF-I-and VIP-CREB-dependent gene transcription were examined using GH4C1 cells transiently transfected with a CRE reporter gene. IGF-I and VIP stimulation of CRE-mediated transcription required activation of both Ras-MAPK and cAMP/PKA signaling. This activation was blocked in the presence of Rap1 GAP1. In summary, we showed that IGF-I and VIP stimulated MAPK activity and the phosphorylation of CREB in pituitary cells. Furthermore, VIP-dependent activation of PKA-Rap1-ERK pathways mediated VIP and IGF-I effects on CREB-dependent transcription in GH4C1 cells. Thus, it is possible that VIP- and IGF-I-induced lactotroph proliferation may involve Rap1.
This article has been cited by other articles:
![]() |
B. Alvarez-Castelao, I. Martin-Guerrero, A. Garcia-Orad, and J. G. Castano Cytomegalovirus Promoter Up-regulation Is the Major Cause of Increased Protein Levels of Unstable Reporter Proteins after Treatment of Living Cells with Proteasome Inhibitors J. Biol. Chem., October 9, 2009; 284(41): 28253 - 28262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cao, J.-i. Hanai, P. Tanksale, S. Imamura, V. P. Sukhatme, and S. H. Lecker Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect FASEB J, September 1, 2009; 23(9): 2844 - 2854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Zaballos, B. Garcia, and P. Santisteban G{beta}{gamma} Dimers Released in Response to Thyrotropin Activate Phosphoinositide 3-Kinase and Regulate Gene Expression in Thyroid Cells Mol. Endocrinol., May 1, 2008; 22(5): 1183 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, D. W. Wolff, M.-F. Lin, and Y. Tu Vasoactive Intestinal Peptide Transactivates the Androgen Receptor through a Protein Kinase A-Dependent Extracellular Signal-Regulated Kinase Pathway in Prostate Cancer LNCaP Cells Mol. Pharmacol., July 1, 2007; 72(1): 73 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I Arroba, A. M Lechuga-Sancho, L. M Frago, J. Argente, and J. A Chowen Cell-specific expression of X-linked inhibitor of apoptosis in the anterior pituitary of streptozotocin-induced diabetic rats J. Endocrinol., January 1, 2007; 192(1): 215 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Romano, M. Pertuit, R. Rasolonjanahary, J.-V. Barnier, K. Magalon, A. Enjalbert, and C. Gerard Regulation of the RAP1/RAF-1/Extracellularly Regulated Kinase-1/2 Cascade and Prolactin Release by the Phosphoinositide 3-Kinase/AKT Pathway in Pituitary Cells Endocrinology, December 1, 2006; 147(12): 6036 - 6045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |